MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jmig.2024.10.024

Медицинская библиотека · Journal of minimally invasive gynecology · 2024

Dutch Nationwide Multicenter Prospective Cohort of Essure-Related Symptomatology After Removal Surgery.

Maassen Liselotte W, van Gastel Danielle M, Koks Carolien A M, Huirne Judith A F, Koning Aafke M H, Graziosi Giuseppe C M, Bouma Linda S, Knauff Erik A H, van Zon-Rabelink Ingrid A A, Bongers Marlies Y, Veersema Sebastiaan

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

STUDY

OBJECTIVE

Essure is a hysteroscopic sterilization device that has been used in the Netherlands since 2003. Essure has received a lot of publicity due to many reported symptoms associated with the device. Because of this, increasing numbers of patients requested surgical removal of Essure devices. There is still limited data available regarding the effect of removal surgery on reported symptoms and patient satisfaction. The aim of this study was to analyze the effect of Essure removal surgery on reported symptoms and quality of life (QoL).

DESIGN

Multicenter prospective study in the Netherlands.

SETTING

Secondary non-teaching hospitals and secondary and tertiary teaching hospitals.

PATIENTS: Patients with Essure-associated symptoms and a request for surgical removal of devices.

INTERVENTIONS: Participants were asked to fill out questionnaires at their first clinic visit and 3 and 12 months after removal surgery. Questionnaires included questions regarding patient characteristics, symptoms, and QoL (SF-36). Clinicians also filled in 2 questionnaires regarding peroperative findings, the removal surgery, and post-operative recovery.

MEASUREMENTS AND MAIN

RESULTS

A total of, 1248 patients in 32 hospitals were included in the period between May 2016 and April 2019. Mean age was 42.9 years (25-63 years). Most frequent reported symptoms were mood swings (72.4%), fatigue (71.8%), pain in hips, legs, or groins (68.3%) and abdominal pain (62.3%). Essure was predominantly removed by laparoscopic salpingectomy (87.3%). Mean follow-up time was 17 months (± 10.8). 3 and 12 months after removal surgery, all reported symptoms significantly improved. QoL improved significantly in all 9 domains.

CONCLUSION

Essure removal surgery was associated with improvement in reported symptoms and QoL. Patients presenting with Essure-related symptoms, should be offered Essure removal surgery, after considering the patient-specific risks for surgery.

Для цитирования: Maassen Liselotte W, van Gastel Danielle M, Koks Carolien A M, Huirne Judith A F, Koning Aafke M H, Graziosi Giuseppe C M, Bouma Linda S, Knauff Erik A H, van Zon-Rabelink Ingrid A A, Bongers Marlies Y, Veersema Sebastiaan. Dutch Nationwide Multicenter Prospective Cohort of Essure-Related Symptomatology After Removal Surgery.. Journal of minimally invasive gynecology. 2024. DOI: 10.1016/j.jmig.2024.10.024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.